These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 10811030)

  • 1. Protease inhibitors. Part 2. Weakly basic thrombin inhibitors incorporating sulfonyl-aminoguanidine moieties as S1 anchoring groups: synthesis and structure-activity correlations.
    Clare BW; Scozzafava A; Briganti F; Iorga B; Supuran CT
    J Enzyme Inhib; 2000; 15(3):235-64. PubMed ID: 10811030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protease inhibitors: synthesis and QSAR study of novel classes of nonbasic thrombin inhibitors incorporating sulfonylguanidine and O-methylsulfonylisourea moieties at P1.
    Supuran CT; Scozzafava A; Briganti F; Clare BW
    J Med Chem; 2000 May; 43(9):1793-806. PubMed ID: 10794696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protease inhibitors: Part 4. Synthesis of weakly basic thrombin inhibitors incorporating pyridinium-sulfanilylaminoguanidine moieties.
    Supuran CT; Briganti F; Scozzafava A; Ilies MA
    J Enzyme Inhib; 2000; 15(4):335-56. PubMed ID: 10995066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protease inhibitors, part 13: Specific, weakly basic thrombin inhibitors incorporating sulfonyl dicyandiamide moieties in their structure.
    Clare BW; Scozzafava A; Supuran CT
    J Enzyme Inhib; 2001 Jan; 16(1):1-13. PubMed ID: 11496831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protease inhibitors - Part 3. Synthesis of non-basic thrombin inhibitors incorporating pyridinium-sulfanilylguanidine moieties at the P1 site.
    Scozzafava A; Briganti F; Supuran CT
    Eur J Med Chem; 1999 Nov; 34(11):939-952. PubMed ID: 10889318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design of weakly basic thrombin inhibitors incorporating novel P1 binding functions: molecular and X-ray crystallographic studies.
    De Simone G; Menchise V; Omaggio S; Pedone C; Scozzafava A; Supuran CT
    Biochemistry; 2003 Aug; 42(30):9013-21. PubMed ID: 12885234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the structures of the cyclotheonamide A complexes of human alpha-thrombin and bovine beta-trypsin.
    Ganesh V; Lee AY; Clardy J; Tulinsky A
    Protein Sci; 1996 May; 5(5):825-35. PubMed ID: 8732754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Azetidin-2-one derivatives as inhibitors of thrombin.
    Han WT; Trehan AK; Wright JJ; Federici ME; Seiler SM; Meanwell NA
    Bioorg Med Chem; 1995 Aug; 3(8):1123-43. PubMed ID: 7582985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of benzothiazole guanidines as novel inhibitors of thrombin and trypsin IV.
    Karle M; Knecht W; Xue Y
    Bioorg Med Chem Lett; 2012 Jul; 22(14):4839-43. PubMed ID: 22726924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Highly selective mechanism-based thrombin inhibitors: structures of thrombin and trypsin inhibited with rigid peptidyl aldehydes.
    Krishnan R; Zhang E; Hakansson K; Arni RK; Tulinsky A; Lim-Wilby MS; Levy OE; Semple JE; Brunck TK
    Biochemistry; 1998 Sep; 37(35):12094-103. PubMed ID: 9724521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and biological evaluation of selective boron-containing thrombin inhibitors.
    Wienand A; Ehrhardt C; Metternich R; Tapparelli C
    Bioorg Med Chem; 1999 Jul; 7(7):1295-307. PubMed ID: 10465405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and synthesis of potent and highly selective thrombin inhibitors.
    Hilpert K; Ackermann J; Banner DW; Gast A; Gubernator K; Hadváry P; Labler L; Müller K; Schmid G; Tschopp TB
    J Med Chem; 1994 Nov; 37(23):3889-901. PubMed ID: 7966150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Geometry of binding of the benzamidine- and arginine-based inhibitors N alpha-(2-naphthyl-sulphonyl-glycyl)-DL-p-amidinophenylalanyl-pipe ridine (NAPAP) and (2R,4R)-4-methyl-1-[N alpha-(3-methyl-1,2,3,4-tetrahydro-8- quinolinesulphonyl)-L-arginyl]-2-piperidine carboxylic acid (MQPA) to human alpha-thrombin. X-ray crystallographic determination of the NAPAP-trypsin complex and modeling of NAPAP-thrombin and MQPA-thrombin.
    Bode W; Turk D; Stürzebecher J
    Eur J Biochem; 1990 Oct; 193(1):175-82. PubMed ID: 2226434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and characterisation of novel thrombin inhibitors based on 4-amidinophenylalanine.
    Reers M; Koschinsky R; Dickneite G; Hoffmann D; Czech J; Stüber W
    J Enzyme Inhib; 1995; 9(1):61-72. PubMed ID: 8568567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design of P1' and P3' residues of trivalent thrombin inhibitors and their crystal structures.
    Slon-Usakiewicz JJ; Sivaraman J; Li Y; Cygler M; Konishi Y
    Biochemistry; 2000 Mar; 39(9):2384-91. PubMed ID: 10694407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-depth study of tripeptide-based alpha-ketoheterocycles as inhibitors of thrombin. Effective utilization of the S1' subsite and its implications to structure-based drug design.
    Costanzo MJ; Almond HR; Hecker LR; Schott MR; Yabut SC; Zhang HC; Andrade-Gordon P; Corcoran TW; Giardino EC; Kauffman JA; Lewis JM; de Garavilla L; Haertlein BJ; Maryanoff BE
    J Med Chem; 2005 Mar; 48(6):1984-2008. PubMed ID: 15771442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amidinohydrazones as guanidine bioisosteres: application to a new class of potent, selective and orally bioavailable, non-amide-based small-molecule thrombin inhibitors.
    Soll RM; Lu T; Tomczuk B; Illig CR; Fedde C; Eisennagel S; Bone R; Murphy L; Spurlino J; Salemme FR
    Bioorg Med Chem Lett; 2000 Jan; 10(1):1-4. PubMed ID: 10636229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protease inhibitors: synthesis of a series of bacterial collagenase inhibitors of the sulfonyl amino acyl hydroxamate type.
    Clare BW; Scozzafava A; Supuran CT
    J Med Chem; 2001 Jun; 44(13):2253-8. PubMed ID: 11405662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Active site-directed thrombin inhibitors--II. Studies related to arginine/guanidine bioisosteres.
    St Laurent DR; Balasubramanian N; Han WT; Trehan A; Federici ME; Meanwell NA; Wright JJ; Seiler SM
    Bioorg Med Chem; 1995 Aug; 3(8):1145-56. PubMed ID: 7582986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrinolytic compromise by simultaneous administration of site-directed inhibitors of thrombin.
    Callas D; Bacher P; Iqbal O; Hoppensteadt D; Fareed J
    Thromb Res; 1994 May; 74(3):193-205. PubMed ID: 8042188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.